Radim Bečvář

6.7k total citations · 1 hit paper
36 papers, 4.4k citations indexed

About

Radim Bečvář is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Rheumatology. According to data from OpenAlex, Radim Bečvář has authored 36 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 10 papers in Molecular Biology and 9 papers in Rheumatology. Recurrent topics in Radim Bečvář's work include Systemic Sclerosis and Related Diseases (25 papers), Dermatologic Treatments and Research (7 papers) and Connective Tissue Growth Factor Research (6 papers). Radim Bečvář is often cited by papers focused on Systemic Sclerosis and Related Diseases (25 papers), Dermatologic Treatments and Research (7 papers) and Connective Tissue Growth Factor Research (6 papers). Radim Bečvář collaborates with scholars based in Czechia, Germany and Switzerland. Radim Bečvář's co-authors include Michal Tomčík, Ladislav Šenolt, Jörg H. W. Distler, Karel Pavelká, Jiří Vencovský, Hana Štorkánová, Maja Špiritović, Barbora Heřmánková, Sabína Oreská and Martin Komarc and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Annals of the New York Academy of Sciences.

In The Last Decade

Radim Bečvář

32 papers receiving 4.4k citations

Hit Papers

Plasma Hsp90 levels in patients with systemic sclerosis a... 2021 2026 2022 2024 2021 1000 2.0k 3.0k 4.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Radim Bečvář Czechia 11 807 668 491 420 333 36 4.4k
Maja Špiritović Czechia 10 803 1.0× 605 0.9× 491 1.0× 420 1.0× 334 1.0× 39 4.3k
Hana Štorkánová Czechia 8 803 1.0× 592 0.9× 491 1.0× 420 1.0× 334 1.0× 34 4.2k
Martin Komarc Czechia 22 876 1.1× 732 1.1× 680 1.4× 438 1.0× 334 1.0× 82 5.4k
Sabína Oreská Czechia 8 803 1.0× 595 0.9× 491 1.0× 420 1.0× 334 1.0× 37 4.2k
Barbora Heřmánková Czechia 8 803 1.0× 587 0.9× 491 1.0× 420 1.0× 334 1.0× 29 4.2k
Kristýna Bubová Czechia 7 802 1.0× 560 0.8× 491 1.0× 420 1.0× 333 1.0× 17 4.2k
Michal Tomčík Czechia 27 818 1.0× 1.5k 2.3× 492 1.0× 421 1.0× 334 1.0× 91 6.4k
Johannes Matiasek Austria 10 1.1k 1.3× 1.0k 1.5× 767 1.6× 676 1.6× 358 1.1× 21 6.7k
Nenad Nikolić Austria 2 1.1k 1.3× 1.0k 1.5× 766 1.6× 676 1.6× 358 1.1× 2 6.5k
Ladislav Šenolt Czechia 37 840 1.0× 2.0k 3.0× 496 1.0× 422 1.0× 334 1.0× 174 8.4k

Countries citing papers authored by Radim Bečvář

Since Specialization
Citations

This map shows the geographic impact of Radim Bečvář's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Radim Bečvář with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Radim Bečvář more than expected).

Fields of papers citing papers by Radim Bečvář

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Radim Bečvář. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Radim Bečvář. The network helps show where Radim Bečvář may publish in the future.

Co-authorship network of co-authors of Radim Bečvář

This figure shows the co-authorship network connecting the top 25 collaborators of Radim Bečvář. A scholar is included among the top collaborators of Radim Bečvář based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Radim Bečvář. Radim Bečvář is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oreská, Sabína, Hana Štorkánová, Ondřej Kodet, et al.. (2025). Serum IL-40 is elevated in systemic sclerosis and is linked to disease activity, gastrointestinal involvement, immune regulation and fibrotic processes. Arthritis Research & Therapy. 27(1). 119–119.
2.
Heřmánková, Barbora, Sabína Oreská, Maja Špiritović, et al.. (2024). Sexual function and pelvic floor function in men with systemic sclerosis compared to healthy controls: a cross-sectional study. The Aging Male. 27(1). 2336630–2336630.
3.
Hachulla, É., Y. Allanore, Gabriela Riemekasten, et al.. (2024). OP0019 INCIDENCE AND RISK FACTORS FOR NEW ONSET INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: INSIGHTS FROM AN ANALYSIS OF THE EUSTAR COHORT. Annals of the Rheumatic Diseases. 83. 66–68. 1 indexed citations
4.
Oreská, Sabína, Barbora Heřmánková, Hana Štorkánová, et al.. (2024). AB1207 RITUXIMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS NON-RESPONSIVE TO CsDMARDs – PRELIMINARY RESULTS OF A PROSPECTIVE, OBSERVATIONAL, MONOCENTRIC STUDY. Annals of the Rheumatic Diseases. 83. 1941–1941. 1 indexed citations
5.
Štorkánová, Hana, Thuong Trinh‐Minh, Hana Hulejová, et al.. (2023). S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin. Lara D. Veeken. 63(3). 817–825. 6 indexed citations
6.
Heřmánková, Barbora, Maja Špiritović, Sabína Oreská, et al.. (2023). Effect of an 8-Week Tailored Physiotherapy Program on Sexual Health in Women with Scleroderma and Myositis: A Controlled Pilot Study. Rheumatology and Therapy. 10(4). 1089–1105. 1 indexed citations
7.
Štorkánová, Hana, Lucie Andrés Cerezo, Sabína Oreská, et al.. (2021). AB0410 S100A4 PLASMA LEVELS CORRELATE WITH DISEASE ACTIVITY, SKIN FIBROSIS AND INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS PATIENTS. Annals of the Rheumatic Diseases. 80. 1233–1233. 2 indexed citations
8.
Štorkánová, Hana, Sabína Oreská, Maja Špiritović, et al.. (2021). Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study. Scientific Reports. 11(1). 1–1. 4074 indexed citations breakdown →
9.
Heřmánková, Barbora, Maja Špiritović, Hana Šmucrová, et al.. (2020). SAT0324 SEXUAL HEALTH IN WOMEN AND MEN WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL STUDY. Annals of the Rheumatic Diseases. 79. 1107–1108. 1 indexed citations
10.
Tomčík, Michal, Katrin Palumbo‐Zerr, Pawel Zerr, et al.. (2015). Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis. Annals of the Rheumatic Diseases. 75(3). 609–616. 36 indexed citations
11.
Tomčík, Michal, Pawel Zerr, Katrin Palumbo‐Zerr, et al.. (2015). Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease. Lara D. Veeken. 54(12). kev260–kev260. 30 indexed citations
12.
Tomčík, Michal, Katrin Palumbo‐Zerr, Pawel Zerr, et al.. (2014). S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis. Annals of the Rheumatic Diseases. 74(9). 1748–1755. 57 indexed citations
13.
Tomčík, Michal, Pawel Zerr, Katrin Palumbo‐Zerr, et al.. (2013). Heat shock protein 90 (Hsp90) inhibition targets canonical TGF-β signalling to prevent fibrosis. Annals of the Rheumatic Diseases. 73(6). 1215–1222. 81 indexed citations
14.
Jansa, Pavel, Radim Bečvář, David Ambrož, et al.. (2011). Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic. Clinical Rheumatology. 31(3). 557–561. 11 indexed citations
15.
Bečvář, Radim, Hana Hulejová, M. Braun, & Jiří Štork. (2007). Collagen Degradation Products and Proinfiammatory Cytokines in Systemic and Localized Scleroderma. Folia Biologica. 53(2). 66–68. 5 indexed citations
16.
Bečvář, Radim, et al.. (2005). Clinical Correlations of Potential Activity Markers in Systemic Sclerosis. Annals of the New York Academy of Sciences. 1051(1). 404–412. 15 indexed citations
17.
Pock, Lumír, et al.. (2001). Verrucous form of chilblain lupus erythematosus. Journal of the European Academy of Dermatology and Venereology. 15(5). 448–451. 10 indexed citations
18.
Bečvář, Radim, Anna Filipowicz‐Sosnowska, S Mackiewicz, et al.. (1999). Nabumetone Induces Less Gastrointestinal Mucosal Changes Than Diclofenac Retard. Clinical Rheumatology. 18(4). 273–278. 2 indexed citations
19.
Rychlík, Ivan, M Merta, Jiřina Bartůňková, et al.. (1997). [Cytokines and adhesion molecules in renal vasculitis and lupus nephritis].. PubMed. 136(16). 501–6. 1 indexed citations
20.
Bečvář, Radim, et al.. (1991). Changes in the gene expression of collagens, fibronectin, integrin and proteoglycans during matrix-induced bone morphogenesis. Biochemical and Biophysical Research Communications. 177(1). 427–432. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026